Skip to content

QuidelOrtho Corporation QDEL JPAC — Total revenues

Other segment segments

North America
$328.9M-19.1%
EMEA
$92.5M+4.0%
Latin America
$64.9M+20.0%
China
$63.5M-15.3%

Similar metrics at other companies

Nuvation Bio logo
NUVBJP — Revenue
$652K+256%
Kyndryl Holdings logo
KDJP — Revenue
$571M-3.1%
Oracle logo
ORCLJP — Revenue
$467.5M+6.3%
Gentherm logo
THRMJP — Revenue
$11.88M-1.8%
A10 Networks logo
ATENAPJ — Total net revenue
$14.2M-23.7%
Schrodinger logo
SDGRAPAC — Total revenues
$20.17M-12.6%

Other financials

Income statement

See full
Revenue$619.8M-10.5%
Gross profit$263.8M-23.2%
Operating income-$31.8M-198%
Net income-$91.8M-623%
EPS (diluted)-$1.35-611%

Balance sheet

See full
Cash & equivalents$140.4M+10.4%
Total debt$3.1B+0.3%
Total equity$1.9B-38.2%
Total assets$5.6B-12.9%

Cash flow

See full
Operating cash flow-$33.0M-150%
CapEx$34.0M-39.5%
Free cash flow-$67.0M-813%

Valuation

See full
Market cap$832.61M-56.1%
Enterprise value$3.8B-22.0%
P/S0.3×-0.4×

Profitability

See full
Gross margin45%-2.0pp
Operating margin-37%-46.2pp
Net margin-45.6%-75.7pp
FCF margin13.8%

Returns & leverage

See full
Return on equity-49.9%-70.8pp
Debt / equity1.7×+0.6×
Current ratio1.4×+0.2×

Where this comes from

Reported directly by QuidelOrtho Corporation in its filing.

Tagged under the XBRL concept us-gaap:Revenues.

The official record: QuidelOrtho Corporation’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about QuidelOrtho Corporation's jpac — total revenues.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is QuidelOrtho Corporation's JPAC — total revenues?
QuidelOrtho Corporation (QDEL) reported JPAC — total revenues of $70M in Q1 2026.
How has QuidelOrtho Corporation's JPAC — total revenues changed year-over-year?
QuidelOrtho Corporation's JPAC — total revenues increased by 2.8% year-over-year, from $68.1M to $70M.
What does JPAC — total revenues mean?
Represents the total gross income generated by the JPAC business segment from the sale of diagnostic testing solutions and services. This figure reflects the segment's market demand and top-line performance within its specific geographic or product-based operational scope.